瀋陽公用發展股份(00747.HK)延遲刊發去年業績
瀋陽公用發展股份(00747.HK)公布,集團截至去年12月31日止年度的財務業績的審計工作由於爆發新型冠型病毒而受阻。經與核數師討論後,公司已總結其未能按照香港聯交所證券上市規則於今年3月31日前取得核數師同意刊發去年全年業績。
董事會決定於今年3月30日刊發公司2019年度的未經審核全年業績公告。倘中國放寬相關旅遊限制,預計核數師將於切實可行情況下儘快恢復實地審計工作。公司將於切實可行情況下儘快刊發截至年度的經審核全年業績公告及年報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.